vs
Forafric Global PLC(AFRI)与Apellis Pharmaceuticals, Inc.(APLS)财务数据对比。点击上方公司名可切换其他公司
Apellis Pharmaceuticals, Inc.的季度营收约是Forafric Global PLC的1.3倍($199.9M vs $159.7M),Forafric Global PLC净利率更高(-7.5% vs -29.5%,领先21.9%),Forafric Global PLC自由现金流更多($146.0K vs $-14.3M)
Forafric Global PLC是一家聚焦非洲市场的农业综合企业,业务覆盖农产品生产、加工、分销全价值链,主营谷物、植物油等主食产品,核心市场为北非和西非地区,服务多领域客户,助力区域粮食安全保障。
Apellis Pharmaceuticals是一家临床阶段生物制药企业,专注于开发调节补体系统的靶向疗法,适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病,核心市场为美国及欧盟地区。
AFRI vs APLS — 直观对比
营收规模更大
APLS
是对方的1.3倍
$159.7M
净利率更高
AFRI
高出21.9%
-29.5%
自由现金流更多
AFRI
多$14.4M
$-14.3M
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $159.7M | $199.9M |
| 净利润 | $-12.0M | $-59.0M |
| 毛利率 | 10.7% | — |
| 营业利润率 | -2.5% | -25.6% |
| 净利率 | -7.5% | -29.5% |
| 营收同比 | — | -5.9% |
| 净利润同比 | — | -62.2% |
| 每股收益(稀释后) | — | $-0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
AFRI
APLS
| Q4 25 | — | $199.9M | ||
| Q3 25 | — | $458.6M | ||
| Q2 25 | $159.7M | $178.5M | ||
| Q1 25 | — | $166.8M | ||
| Q4 24 | — | $212.5M | ||
| Q3 24 | — | $196.8M | ||
| Q2 24 | $145.6M | $199.7M | ||
| Q1 24 | — | $172.3M |
净利润
AFRI
APLS
| Q4 25 | — | $-59.0M | ||
| Q3 25 | — | $215.7M | ||
| Q2 25 | $-12.0M | $-42.2M | ||
| Q1 25 | — | $-92.2M | ||
| Q4 24 | — | $-36.4M | ||
| Q3 24 | — | $-57.4M | ||
| Q2 24 | $-8.6M | $-37.7M | ||
| Q1 24 | — | $-66.4M |
毛利率
AFRI
APLS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 10.7% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 9.4% | — | ||
| Q1 24 | — | — |
营业利润率
AFRI
APLS
| Q4 25 | — | -25.6% | ||
| Q3 25 | — | 48.7% | ||
| Q2 25 | -2.5% | -18.6% | ||
| Q1 25 | — | -50.0% | ||
| Q4 24 | — | -12.3% | ||
| Q3 24 | — | -24.0% | ||
| Q2 24 | -0.9% | -14.7% | ||
| Q1 24 | — | -36.0% |
净利率
AFRI
APLS
| Q4 25 | — | -29.5% | ||
| Q3 25 | — | 47.0% | ||
| Q2 25 | -7.5% | -23.6% | ||
| Q1 25 | — | -55.3% | ||
| Q4 24 | — | -17.1% | ||
| Q3 24 | — | -29.2% | ||
| Q2 24 | -5.9% | -18.9% | ||
| Q1 24 | — | -38.5% |
每股收益(稀释后)
AFRI
APLS
| Q4 25 | — | $-0.40 | ||
| Q3 25 | — | $1.67 | ||
| Q2 25 | — | $-0.33 | ||
| Q1 25 | — | $-0.74 | ||
| Q4 24 | — | $-0.30 | ||
| Q3 24 | — | $-0.46 | ||
| Q2 24 | — | $-0.30 | ||
| Q1 24 | — | $-0.54 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $12.2M | $466.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $5.3M | $370.1M |
| 总资产 | $246.1M | $1.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
AFRI
APLS
| Q4 25 | — | $466.2M | ||
| Q3 25 | — | $479.2M | ||
| Q2 25 | $12.2M | $370.0M | ||
| Q1 25 | — | $358.4M | ||
| Q4 24 | — | $411.3M | ||
| Q3 24 | — | $396.9M | ||
| Q2 24 | $16.4M | $360.1M | ||
| Q1 24 | — | $325.9M |
总债务
AFRI
APLS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $18.4M | — | ||
| Q1 24 | — | $93.1M |
股东权益
AFRI
APLS
| Q4 25 | — | $370.1M | ||
| Q3 25 | — | $401.2M | ||
| Q2 25 | $5.3M | $156.3M | ||
| Q1 25 | — | $164.2M | ||
| Q4 24 | — | $228.5M | ||
| Q3 24 | — | $237.1M | ||
| Q2 24 | $16.3M | $264.3M | ||
| Q1 24 | — | $266.7M |
总资产
AFRI
APLS
| Q4 25 | — | $1.1B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | $246.1M | $821.4M | ||
| Q1 25 | — | $807.3M | ||
| Q4 24 | — | $885.1M | ||
| Q3 24 | — | $901.9M | ||
| Q2 24 | $287.1M | $904.5M | ||
| Q1 24 | — | $831.9M |
负债/权益比
AFRI
APLS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.13× | — | ||
| Q1 24 | — | 0.35× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $706.0K | $-14.2M |
| 自由现金流经营现金流 - 资本支出 | $146.0K | $-14.3M |
| 自由现金流率自由现金流/营收 | 0.1% | -7.1% |
| 资本支出强度资本支出/营收 | 0.4% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $45.0M |
8季度趋势,按日历期对齐
经营现金流
AFRI
APLS
| Q4 25 | — | $-14.2M | ||
| Q3 25 | — | $108.5M | ||
| Q2 25 | $706.0K | $4.4M | ||
| Q1 25 | — | $-53.4M | ||
| Q4 24 | — | $19.4M | ||
| Q3 24 | — | $34.1M | ||
| Q2 24 | $10.5M | $-8.3M | ||
| Q1 24 | — | $-133.0M |
自由现金流
AFRI
APLS
| Q4 25 | — | $-14.3M | ||
| Q3 25 | — | $108.3M | ||
| Q2 25 | $146.0K | $4.4M | ||
| Q1 25 | — | $-53.4M | ||
| Q4 24 | — | $19.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | $6.4M | $-8.4M | ||
| Q1 24 | — | $-133.3M |
自由现金流率
AFRI
APLS
| Q4 25 | — | -7.1% | ||
| Q3 25 | — | 23.6% | ||
| Q2 25 | 0.1% | 2.5% | ||
| Q1 25 | — | -32.0% | ||
| Q4 24 | — | 9.1% | ||
| Q3 24 | — | — | ||
| Q2 24 | 4.4% | -4.2% | ||
| Q1 24 | — | -77.3% |
资本支出强度
AFRI
APLS
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | 0.4% | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | 2.8% | 0.0% | ||
| Q1 24 | — | 0.2% |
现金转化率
AFRI
APLS
| Q4 25 | — | — | ||
| Q3 25 | — | 0.50× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AFRI
| Sales to external customers, Total | $159.7M | 100% |
| Couscous & Pasta | $934.0K | 1% |
| Soft Wheat | $393.0K | 0% |
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |